Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126987421 | 12698742 | 1 | I | 20160818 | 20160830 | 20160830 | EXP | GR-NOVOPROD-507448 | NOVO NORDISK | 75.00 | YR | E | M | Y | 81.00000 | KG | 20160830 | CN | GR | GR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126987421 | 12698742 | 1 | PS | TRESIBA | INSULIN DEGLUDEC | 1 | Subcutaneous | 32 U, QD MORNING | U | U | UNKNOWN | 203314 | 32 | DF | SOLUTION FOR INJECTION | QD | |||
126987421 | 12698742 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK | U | U | UNKNOWN | 0 | TABLET | ||||||
126987421 | 12698742 | 3 | SS | ATROST | ATORVASTATIN CALCIUM | 1 | Oral | UNK | U | U | UNKNOWN | 0 | TABLET | ||||||
126987421 | 12698742 | 4 | C | NovoMix 30 FlexPen | INSULIN ASPART | 1 | Subcutaneous | 8 IU PRN | UNKNOWN | 0 | SUSPENSION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126987421 | 12698742 | 1 | Type 2 diabetes mellitus |
126987421 | 12698742 | 2 | Hyperlipidaemia |
126987421 | 12698742 | 3 | Hyperlipidaemia |
126987421 | 12698742 | 4 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126987421 | 12698742 | HO |
126987421 | 12698742 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126987421 | 12698742 | Alanine aminotransferase increased | |
126987421 | 12698742 | Aspartate aminotransferase increased | |
126987421 | 12698742 | Blood creatine phosphokinase increased | |
126987421 | 12698742 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |